China Shineway Pharmaceutical Group Limited (2877.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
| Market Cap | 5.84B |
| Enterprise Value | -1.02B |
| P/E Ratio | 5.85 |
| PEG Ratio | -1.59 |
| Price/Sales Ratio | 1.75 |
| Price/Book Ratio | 0.57 |
| Enterprise/Revenue | -0.98 |
| Enterprise/EBITDA | -3.26 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.3 |
| Operating Margin | 0.24 |
| Return On Assets | 0.08 |
| Return On Equity | 0.1 |
| Revenue | 3.14B |
| Revenue/Share | 3.5 |
| Gross Profit | 2.27B |
| EBITDA | 752.95M |
| Net Income | 949.95M |
| Diluted EPS | 1.26 |
| Total Cash | 7.54B |
| Total Cash/Share | 9.98 |
| Total Debt | 312.23M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 4.32 |
| Book Value Per Share | 10.86 |
| 52-Week Change | -15.36 |
| 52-Week High | 10.47 |
| 52-Week Low | 7.12 |
| Moving Average 50 Days | 7.98 |
| Moving Average 200 Days | 8.7 |
| Average Volume | 1.46M |
| Shares Outstanding | 755.4M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 2.06 |
| Trailing Annual Dividend Yield | 33.45 |
| Payout Ratio | 0.52 |
| Last Split Factor | N/A |
| Last Split Date | N/A |